FindTrial
Sign In

We are assessing the effectiveness of high supply of oxygen when patient is not breathing during Fibre Optic Intubation under General Anaesthesia

TO EVALUATE THE EFFICACY OF HIGH FLOW NASAL OXYGENATION DURING ORAL FIBREOPTIC TRACHEAL INTUBATION UNDER GENERAL ANAESTHESIA. - NILL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/08/056194
Enrollment
45
Registered
2023-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr. Bhavyashree. V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient aged 18 - 65 years Patients with Mallampati grade I and II Patients belonging to American Society of Anaesthesiologists Physical Status (ASA-PS)I and II

Exclusion criteria

Exclusion criteria: Patients with history of stridor and or obstructive sleep apnea (OSA) Patients with known airway pathology, DNS and morbid obesity Pregnant and lactating mothers

Design outcomes

Primary

MeasureTime frame
To observe the oxygen saturation during the Oral Fibreoptic Intubation following preoxygenation & apnoeic oxygenation with high flow nasal cannula.Timepoint: Perioperative, until patient is shifted from the recovery room—

Secondary

MeasureTime frame
To observe the oxygen saturation during the Oral Fibreoptic Intubation following preoxygenation & apnoeic oxygenation with high flow nasal cannula.Timepoint: After induction to larygoscopy & intubation;To observe the oxygen saturation during the Oral Fibreoptic Intubation following preoxygenation & apnoeic oxygenation with high flow nasal cannula.Timepoint: After induction to larygoscopy & intubation—

Countries

India

Contacts

Public ContactDr Bhavyashree V

Dr. B. R. Ambedkar Medical College and Hospital

harsoorss@gmail.com9845279426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026